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C16H18N2O4 
Ethyl (1S,3R,3aS,6aR)-5-methyl-3-phenyl-4,6-dioxooctahydropyrrolo[3,4-c]pyrrole-1-carboxylate 
 
 
 
[α]D = = +74º (c 1, CHCl3, 90% ee from HPLC) 
Source of chirality: (S)-Binap 
Absolute configuration: (1S,3R,3aS,6aR) 
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C17H20N2O4 
Isopropyl (1S,3R,3aS,6aR)-5-methyl-3-phenyl-4,6-dioxooctahydropyrrolo[3,4-c]pyrrole-1-carboxylate 
 
 
[α]D = +63º (c 0.7, CHCl3, 99% ee from HPLC) 
Source of chirality: (S)-Binap 
Absolute configuration: (1S,3R,3aS,6aR) 
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C18H22N2O4 
tert-Butyl (1S,3R,3aS,6aR)-5-methyl-3-phenyl-4,6-dioxooctahydropyrrolo[3,4-c]pyrrole-1-carboxylate 
 
 
 
[α]D = +33.9º (c 0.8, CHCl3, 92% ee from HPLC) 
Source of chirality: (S)-Binap 
Absolute configuration: (1S,3R,3aS,6aR) 
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C22H24N2O4 
tert-Butyl (1S,3R,3aS,6aR)-5-methyl-3-(2-naphthyl)-4,6-dioxooctahydropyrrolo[3,4-c]pyrrole-1-carboxylate 
 
 
[α]D = +39.8º (c 1, CHCl3, 92% ee from HPLC, 75:25 endo/exo) 
Source of chirality: (S)-Binap 
Absolute configuration: (1S,3R,3aS,6aR) 
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C16H18N2O4 
(1S,3R,3aS,6aR)-Methyl 5-methyl-4,6-dioxo-3-(o-tolyl)octahydropyrrolo[3,4-c]pyrrole-1-carboxylate 
 
 
 
[α]D = +50.8º (c 0.6, CHCl3, 75% ee from HPLC) 
Source of chirality: (S)-Binap 
Absolute configuration: (1S,3R,3aS,6aR) 
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C19H24N2O5 
tert-Butyl (1S,3R,3aS,6aR)-3-(4-methoxyphenyl)-5-methyl-4,6-dioxooctahydropyrrolo[3,4-c]pyrrole-1-carboxylate 
 
 
 
[α]D = +93º (c 0.5,CHCl3, 84% ee from HPLC) 
Source of chirality: (S)-Binap 
Absolute configuration: (1S,3R,3aS,6aR) 
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C18H21ClN2O4 
tert-Butyl (1S,3R,3aS,6aR)-3-(4-chlorophenyl)-5-methyl-4,6-dioxooctahydropyrrolo[3,4-c]pyrrole-1-carboxylate 
 
 
 
[α]D = +16º (c 0.5, CHCl3, 82% ee from HPLC) 
Source of chirality: (S)-Binap 
Absolute configuration: (1S,3R,3aS,6aR) 
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C17H20N2O4 
Methyl (1S,3R,3aS,6aR)-5-ethyl-3a-methyl-3-phenyl-4,6-dioxooctahydropyrrolo[3,4-c]pyrrole-1-carboxylate 
 
 
 
 
Source of chirality: (S)-Binap 
Absolute configuration: (1S,3R,3aS,6aR) 
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C17H20N2O4 
Methyl (1S,3R,3aS,6aR)-5-ethyl-6a-methyl-3-phenyl-4,6-dioxooctahydropyrrolo[3,4-c]pyrrole-1-carboxylate 
 
 
 
 
Source of chirality: (S)-Binap 
Absolute configuration: (1S,3R,3aS,6aR) 
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C20H27NO6 
(2S,3S,4S,5R)-3,4-Diisopropyl 2-methyl 5-phenylpyrrolidine-2,3,4-tricarboxylate 
 
 
 
 
[α]D = +32.1º (c 0.5, CHCl3, 82% ee from HPLC) 
Source of chirality: (S)-Binap 
Absolute configuration: (2S,3S,4S,5R) 
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C22H31NO6 
(2S,3S,4S,5R)-3,4-Diisobutyl 2-methyl 5-phenylpyrrolidine-2,3,4-tricarboxylate 
 
 
[α]D = +47.1º (c 0.5, CHCl3. 82% ee from HPLC) 
Source of chirality: (S)-Binap 
Absolute configuration: (2S,3S,4S,5R) 
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Abstract—. The enantioselective 1,3-dipolar cycloaddition reaction of stabilized azomethine ylides, generated from iminoesters, with 
maleimides was efficiently achieved by intermediacy of an equimolar mixture of chiral (R)- or (S)-Binap and AgClO4. The high stability of 
the titled catalytic metal-complex to light exposure and its insolubility in toluene made possible its recovery and reutilization in other new 
process. In order to get a better understanding of the behaviour of these chiral catalysts, we have carried out DFT1 calculations 
demonstrating the experimentally observed endo-selectivity through a very asynchronous transition state. © 2009 Elsevier Science. All 
rights reserved. 
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1. Introduction 
 
 Proline is singular among the genetically encoded 
α-amino acids (α-AA) due to the rigidity conferred by its 
pyrrolidine ring, which leads to a steric hindrance 
particularity useful in the design of biologically active 
peptides,1 including the proline rich amphipathic cell-
penetrating peptides.2 The substitution on the pyrrolidine 
heterocycle opens new perspectives formed on these two 
mentioned areas, especially in structure-activity 
relationships studies of the newly generated peptides.1 
Restriction of the conformational space not only concerns 
proline or its derivative itself but also the preceding 
residue. The substituent attached in position 2 of the 
heterocycle (α-methylation) is widely used to stabilize 
helical conformation of peptides, as well as some type I 
β-trans arrangements. However, the substitution in position 
3 has not been so studied and the results are not so 
predictable. Substituted prolines at the 4-position can be 
considered  as  a  constrained  analogues  of  homocysteine 
glutamate, homoarginine and homoserine depending on the 
nature of the functional group used as substituent. These 4-
substituted surrogates, together with prolines incorporating 
a substituent in position 5 use to stabilize type VI β-turns 
conformations and favor the preference of the CV-exo-
puckering in the peptide.1 
 The proline derived structures themselves have been 
employed as organocatalyst3 in many useful 
transformations and also as potent drugs. For example, 
antiviral agents 1, active against hepatitis C virus,4 kainoids 
2 with neuro-excitatory activity or as insecticides,5 
 
Pergamon 
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neuroexcitotoxin (−)-dysibetaine 3.6 Hydroxyprolines 4 and 
5 are crucial in collagen catabolism, and for stabilization of 
protocollagens and glycoproteins in plants and animals,7 
respectively, etc. 
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Figure 1. Some biologically active proline derivatives. 
 
 The synthesis of enantioenriched substituted prolines8 
can be achieved by several routes, as for example, starting 
from prolines or proline derivatives, and through C-N or C-
C bond forming cyclizations. These routes operate under a 
diastereoselective key step included in a large synthetic 
sequence. Since 2002, several fascinating enantioselective 
syntheses of substituted prolines through 1.3-dipolar 
cycloaddition9 (1,3-DC) of azomethine ylides and electron 
poor alkenes have been developed by several groups.10 The 
simultaneous formation of the new three or four 
stereocentres of the resulting pyrrolidine can be achieved 
using chiral complexes of silver,11 copper,12 zinc,13 nickel,14 
calcium,15 or chiral organocatalysts,16 the metal-catalyzed 
reaction being the most efficient and reliable route. 
Particularly, the most elevated endo:exo 
diastereoselectivities and enantioselectivities were obtained 
with mono- or bidentate chiral ligands AgI or CuI 
complexes.  
 
 The combination of (S)-Binap-AgOAc showed low ee 
in 1,3-DC using dipoles derived from iminoesters and 
dimethyl maleate (up to 13% ee) in the first efficient silver-
catalyzed enantioselective 1,3-DC,11a or phenyl vinyl 
sulfone (up to 26% ee),12e,i as dipolarophiles. In our group, 
we have used the Binap ligand17 and AgClO4 to generate 
active catalysts in the 1,3-DC using N-methylmaleimide 
(NMM) and iminoesters.11h In this work, we will describe 
the scope of this reaction as well as the study of another 
diphosphines as well as the origin of the elevated 
enantioselection and endo-diastereoselectivity. 
 
2. Results and discussion 
 
2.1. Optimization of the reaction conditions. 
 The selected model reaction between  methyl 
benzylideneiminoglycinate 6aa and NMM 7 was carried 
out in toluene at room temperature using 5 mol % of (S)-
Binap 8 and 5 mol% of AgI salt as catalyst precursor 
(Scheme 1). 
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Scheme 1.  Reagents and conditions: i) (S)-Diphosphine (5 mol%), AgI 
salt (5 mol%), Et3N (5 mol%), toluene, rt, 16 h. 
 
 The reaction run with the equimolar amount of both 
Binap 8 and silver(I) salts such as AgBF4, AgNO3, Ag2O, (5 
mol%) gave poor results in terms of enantioselection and 
conversion (Table 1, entries 1-3). When AgOAc was used 
excellent results of the compound 6aa were obtained (Table 
1, entry 4), but the crude reaction product was not as clean 
as in the case of AgClO4 does. AgOTf, and AgF were also 
tested obtaining in both cases, not reproducible results 
(Table 1, entries 5 and 6). However, reproducible results of 
a very clear crude 12aa product with excellent 
enantioselectivities (>99% ee), high endo-
diastereoselectivity (>98/2) and 90% yield were achieved 
with AgClO4 (Table 1, entry 7). A 3 mol% of the catalytic 
complex also gave good enantioselections but the reaction 
time was too large (1.5 d, Table 1, entry 8). This AgClO4 
was used rather than the corresponding monohydrate 
because the last one was more difficult to weight (Table 1, 
entry 9). Next, different ratios of Binap:AgClO4 were 
tested. Thus, when it was added a 2:1 mixture of 
Binap:AgClO4 (Table 1, entry 10) the percentage of the 
exo-cycloadduct was increased. When a 1:2 mixture was 
prepared in situ the product 12aa was obtained with a very 
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low enantioselectivity (Table 1, entry 11). In summary, the 
equimolar Binap:AgClO4 was definitively the most 
efficient complex for this process (compare entries 7, 10, 
and 11). 
   
The effect of the solvent was also important because 
almost racemic mixtures were obtained with diethyl ether, 
whilst dichloromethane and THF gave moderate 
enantioselections (<60% ee) of product 12aa.  
 
Three additional diphosphines (9-11) were evaluated in 
this particular model reaction (Scheme 1). It is very well 
known that the improvements of the enantioselection 
promoted by diphosphines was associated to changes in the 
corresponding both dihedral and bite angles of the resulting 
chiral metal complex.18 Thus, equimolar mixtures of silver 
perchlorate and ligands 9, 10, and 11 (5 mol% each) 
afforded cycloadduct endo-12aa with very high 
conversions and excellent enatioselections (>99% ee) 
except in the example of the reaction product generated by 
intermediacy of the chiral complex 11, which was isolated 
with a 98% ee (Table 1, entries 12-14). 
According to these data, the AgI complex formed with 
(R)- and (S)-Binap 8 exhibited almost identical 
enantiodiscrimination than the other complexes generated 
from more expensive chiral ligands 9-11. In addition, the 
resulting equimolar Binap-AgClO4 can be recovered more 
easily than the analogous complexes generated from 
diphosphines 9, 10, and 11.  
The absolute configuration of the four stereocentres of 
known product endo-14aa (2S.3R.4R.5R) was confirmed by 
NOESY experiments and by comparison of the obtained 
data with the previous ones published in the literature.19  
 
  
 
Table 1. Optimization of the reaction of iminoesters 6a with NMM. 
      Product 12a   
Entry Iminoester 6 Ligand AgI salt No. Yield (%)b endo:exoc ee (%)d 
1 6aa 8 AgBF4 12aa 77 89:11 72 
2 6aa 8 AgNO3 12aa 65 85:11 67 
3 6aa 8 Ag2O 12aa 65 90:10 18 
4 6aa 8 AgOAc
 
12aa 89 >98:2 99 
5 6aa 8 AgOTf
 
12aa 88 90:10 99 
6 6aa 8 AgF
 
12aa 81 90:10 98 
7 6aa 8 AgClO4 12aa 90 >98:2 >99 
8 6aa 8 AgClO4e 12aa 90 >98:2 >99 
9 6aa 8 AgClO4·H2O 12aa 89 >98:2 99 
10 6aa 8 AgClO4f 12aa 89 90:10 98 
11 6aa 8 AgClO4g 12aa 91 90:10 <50 
12 6aa 9 AgClO4 12aa 91 >98:2 >99 
13 6aa 10 AgClO4 12aa 90 >98:2 >99 
14 6aa 11 AgClO4 12aa 90 >98:2 98 
 
a The conversions were higher than 95% (determined by 1H NMR spectroscopy).  
b Isolated yield after recrystallization. 
c Determined by 1H NMR spectroscopy of the crude product. 
d
 Determined by chiral HPLC (Daicel Chiralpak AS) of the recrystallized product. 
e
 Reaction performed with a 3 mol% of the catalyst taking more than 1.5 d to complete. 
f
 Reaction performed with 2 equiv. of 8 and 1 equiv. of AgClO4. 
g
 Reaction performed with 1 equiv. of 8 and 2 equiv. of AgClO4. 
 
 
2.2. Characterization and properties of complexes 
formed by (S)-Binap 8 and AgClO4. 
Complexes formed from silver triflate and (R) or (S)-
Binap 9, were isolated at different temperatures and further 
characterized by X-ray diffraction analysis by Yamamoto’s 
group.20 These studies revealed that mixture of structures 
13-15 are in equilibrium and at room temperature, being the 
1:1 complex 14 the most abundant system (Figure 2). 
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Figure 2. [(R)-Binap]AgOTf complexes. 
 
 In spite of equimolar [(S)-Binap]-AgClO4 and [(S)-
Binap]-AgOAc complexes gave identical chemical yields 
of product endo-12aa and very high enantioselection (>99 
and 99% ee, respectively, Table 1, 4 and 7) the presumed 
major complex 16 was much more insoluble in toluene than 
the analogous formed by AgOAc. This property allowed 
the separation of the complex 16 from the reaction mixture 
by simple filtration (see experimental part). Surprisingly, 
complexes (R)- and (S)-16 exhibited a high stability and 
any apparent decomposition occurred upon the light 
exposure. Both complexes 16 and 17 were prepared and 
isolated by reaction with 1 and 2 equiv of (R)- or (S)-Binap 
together to 1 equiv. of AgClO4, respectively. The mixture 
was stirred for 1h at room temperature and the complexes 
were obtained in quantitative yield. Complex (S)-16 was 
further characterized by ESI-MS experiments showing an 
M++1 signal at 731 and a tiny one at 1353 (Graphic 1). In 
the case of complex (S)-17 (Graphic 2), the same 
experiment revealed a peak at 1353 and a very small one at 
731. However, these two in situ formed Binap complexes 
16 and 17 could not be differentiated by 31P NMR 
spectroscopy. Unfortunately, we could not obtain 
appropriate crystals for their comprehensive and definitive 
characterization by X-ray diffraction analysis. 
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Figure 3. Structures of complexes (R)-16, (S)-16, and (S)-17. 
 
Graphic 1. ESI experiments of complex (S)-16. 
 
Graphic 1. ESI experiments of complex (S)-17. 
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 Due to the perchlorates are very hygroscopic materials 
and also classified as low order explosives and not 
excessively sensitive to rubbing the thermogravimetric 
(TG) and differential thermal analysis (DTA) of the stable 
species 16 were studied (Graphic 3). The integrated TG-
DTA plot revealed that the loss of water of the sample 
occurred from 50 to 180 ºC without any variation of the 
heat of the system. The melting point of this complex 16 is 
placed in Graphic 3 in the range of 209-211 ºC. The three 
most important exothermic decomposition processes 
occurred approximately at 300, 550 and 860 ºC. 
 
Graphic 3. TG-DTA plot of complex (S)-16 
 Such as it was described before, the easy separation of 
the most active major complex (S)-16 was a very important 
feature to apply in a larger scale process. So, a series of 
cycles were run employing the same catalytic mixture (1:1 
8-AgClO4), which was recovered and reused without any 
additional purification (Scheme 1 and Table 2). The 
reaction shown in Scheme 1 was performed on a 1 mmol 
scale on 6aa with a 10 mol% of catalyst to facilitate its 
manipulation and successive reutilization. In the cycles 1- 4 
the enantioselectivity was higher than 99% ee keeping 
identical chemical yields (81-91%) (Table 2, entries 1-4). 
The fifth cycle also afforded the title product endo-12aa in 
high yield but with a slightly lower ee (98%) (Table 2, 
entry 5) due to the effect of the possible impurities 
contained in the catalyst. In all of the five cycles tested the 
endo:exo diastereoselectivity was higher than 98:2 
according to 1H NMR experiments. 
Table 2. Recycling experiments of 1:1 [(S)-Binap 8]:AgClO4 complex. 
Cycle Reaction 
(mmol)  
(S)-6aa 
(mmol) a 
Recovered 
Catalyst (%) 
Yield 
(%)b 
eeendo 
(%)c 
1 1 0.100 95 91 >99 
2 1 0.095d 93 89 >99 
3 1 0.088d 92 91 >99 
4 1 0.081d 90 90 99 
5 1 0.073d 90 88 98 
 
a Recovered after filtration of the crude reaction suspension and washed 
several times with toluene.  
b Isolated yield of compound endo-12aa after recrystallization. The 
conversions were >99% and the endo:exo ratio were >98:2 in all of the 
essayed cycles.  
c  Determined by chiral HPLC (Daicel Chiralpak AS).  
d  Amount recovered from the previous cycle. 
 
 The existence of NLE was discarded when the reaction 
shown in the Scheme 1 was performed using different 
optical purities of the in situ generated major complex (S)-
16 (Graphic 4). In this case, an almost linear behavior was 
observed and, in consequence, it was reasonable to assume 
that monomeric complexes can be the catalytically active 
species. 
ee
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Graphic 4. NLE study of the model reaction catalyzed by the presumed 
major complex 16. 
 
2.3. Scope of the 1,3-DC catalyzed by complexes (R)- 
and (S)-16.  
 The scope of the reaction employing different aryl- and 
ester groups at the iminoester structure with assorted 
dipolarophiles, was surveyed. Several ester and aryl groups 
were appropriate substituents in iminoglycinates 6 to 
perform efficiently the 1,3-DC with NMM 11 (Scheme 2 
and Table 3). 
N
H
N
CO2MeAr
OO
endo-12
Ar N CO2Me
6
+  7
i
 
Scheme 2. Reagents and conditions: i) (S)-Binap 8 (5 mol%), AgClO4 (5 
mol%), base (5 mol%), toluene, rt, 16 h. 
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Table 3. 1.3-DC of iminoglycinates 6 and NMM 7. 
     Product endo-12 
Entry Nº Ar R Base Nº Yield. (%)a endo:exob eeendo (%)c 
1 6aa Ph Me Et3N 12aa 90 >98:2 >99 (>99)d 
2 6aa Ph Me Et3N 12aae 90 >98:2 >99 (>99)d 
3 6ab Ph Et Et3N 12ab 78 90:10 90 (91) 
4 6ac Ph Pri Et3N 12ac 80 90:10 70 (72) 
5 6ad Ph But Et3N 12ad 81 75:25 92 (92) 
6 6ba 2-naphthyl Me Et3N 12ba 89 >98:2 99 (>99)d 
7 6bd 2-naphthyl But Et3N 12bd 87 95:5 92 (94) 
8 6ca 2-CH3C6H4 Me Et3N 12ca 85f >98:2 70 (75) 
9 6da 2-ClC6H4 Me Et3N 12da 82f >98:2 82 (85) 
10 6da 2-ClC6H4 Me Et3N 12da 82f,g >98:2 82 (85) 
11 6ea 4-CH3C6H4 Me Et3N 12ea 88 >98:2 86 (88)d 
12 6ea 4-CH3C6H4 Me DBU 12ea 88 >98:2 99 (>99)d 
13 6fa 4-(CH3O)C6H4 Me Et3N 12fa 85 >98:2 80 (99) 
14 6fa 4-(CH3O)C6H4 Me Et3N 12fa 85g >98:2 80 (99) 
15 6fd 4-(CH3O)C6H4 But Et3N 12fd 84 95:5 90 (91) 
16 6ga 4-ClC6H4 Me Et3N 12ga 87 >98:2 64 (65) 
17 6ga 4-ClC6H4 Me DBU 12ga 87g >98:2 98 (99) 
18 6gd 4-ClC6H4 But Et3N 12gd 83 >98:2 80 (80) 
19 6ha 2-thienyl Me Et3N 12ha 87 >98:2 90 (92)h 
20 6ha 2-thienyl Me Et3N 12ha 87g >98:2 90 (92)h 
 
a Isolated yield after recrystallization. 
b Determined by 1H-MNR.  
c  Determined by chiral HPLC (Chiralcel OD-H), in parenthesis the results of the recrystallized  product..  
d  Determined by chiral HPLC (Chiralpak AS).  
e  Molecule (2R.3S.4S.5S) endo-12aa obtained employing (R)-16.  
f
  Purification by flash chromatography. 
g
  Reaction performed with the recycled catalytic mixture. 
h
  Determined by chiral HPLC (Chiralpak AD). 
 
 
Non-substituted methyl aryliminoglycinates 6, derived 
from benzaldehyde and 2-naphthalenecarbaldehyde, were 
the best substrates affording >99% ee (Table 3, entries 1, 2, 
and 6). In the example performed with catalytic complex 
(R)-16, the corresponding enantiomer (2S.3R.4R.5R)-endo-
12aa was obtained (Table 3, entry 2). It was also 
demonstrated for these phenyl and 2-naphthyl derivatives 
that ethyl, isopropyl, and tert-butyl iminoglycinates were 
not suitable groups for obtaining the highest 
enantioselections (Table 3, entries 3, 4, 5, and 7). In these 
examples, it was also observed that larger amounts of the 
exo-diastereoisomer 12 were formed according to 1H NMR 
spectroscopy and chiral HPLC. More sterically hindered 
iminoglycinates derived from ortho-substituted aromatic 
aldehydes gave lower enantioselections (Table 3, entries 8 
and 9), even working at 0 or −20 ºC and with other bases 
different to Et3N, such as DBU or DIEA. Using Et3N as 
base, the imines derived from electron-donating or 
electron-withdrawing para-substituted aromatic aldehydes 
shown a very similar tendency (Table 3, compare entries 
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11, 13, 14 and 16). In a few compounds the ee was 
increased after recrystallization of the previously purified 
sample endo-12fa (Table 3, entry 13), but in other 
situations the employment of DBU as base at 0 ºC resulted 
to be crucial in order to achieve excellent enantioselections 
of endo-12ea and endo-12ga (Table 3, entries 12 and 17). 
Unlike the results described from phenyl and naphthyl 
derivatives the terc-butyl esters were more effective than 
the corresponding methyl esters in those examples 
containing a para-substituted aromatic residue imino group 
(compare entries 13 and 15, 16 and 18 of Table 3). 
Heteroaromatic iminoglycinate bearing a 2-thienyl group 
furnished endo-cycloadduct 12ha with 92% ee after 
recrystallization (Table 3, entry 19). The recovery of the 
complex (S)-16 was successfully attempted in the examples 
recorded in entries 10, 14 and 20 of the Table 3 in 88-93% 
yield by simple filtration. 
 
Next, sterically hindered α-substituted benzaldimino 
esters were tested as substrate in this 1,3-DC with NMM. 
Methyl benzylidenealaninate 18, methyl 
phenyliminophenylalaninate 19 and methyl 
2-thienyliminoleucinate 20 reacted with NMM under the 
same reaction conditions at room temperature for 48 h 
(Scheme 3). Cycloadducts endo-21-23 were 
diastereoselectivity obtained (>98:2 endo:exo ratio) and 
with good enantioselections (72-76% ee). However, 
compound endo-22 was obtained after recrystallization in 
98% ee, and 58% yield (Scheme 3). The absolute 
configuration of the heterocycle (2R.3S.4S.5S) endo-21 was 
determined X-ray diffraction analysis (Figure 4). 2-Thienyl 
derivatives endo-12ha and endo-23 can be considered as 
structurally related precursors of active inhibitors of the 
virus responsible of the hepatitis C 1 (Figure 1).11i,21 
 
N
H
N
CO2MePh
OO
endo-21
Ph N CO2Me
18
+
i
80%
N
H
N
CO2MePh
OO
endo-22
Ph N CO2Me
19
+
i
83%
N
H
N
CO2Me
OO
endo-23
N CO2Me
20
+
i
81%
Ph
Ph
S
NMM
7
NMM
7
NMM
7
72% ee
64% ee
74% ee
After recryst. 56%, 98% ee
S
 
Scheme 3. Reagents and conditions: i) (S)-Binap 8 (5 mol%), AgClO4 (5 
mol%), Et3N (5 mol%), toluene, rt, 48 h. 
 
 
Figure 4. ORTEP of cycloadduct endo-21. 
 
Several maleimides were essayed employing the model 
reaction described in Scheme 1, that means 
benzyliminoglycinate 6aa, room temperature, (S)-8 (5 
mol%), AgClO4(5 mol%) and Et3N (5 mol%) in toluene. N-
Ethylmaleimide afforded similar results of endo-24 to the 
analogous obtained with NMM 7 after 8 h of reaction 
(Figure 5). Nevertheless, the bulkier N-phenylmaleimide 
(NPM) furnished lower ee (62%) of endo-25 and lower 
diastereoselectivity (90:10 endo:exo ratio) (Figure 5). 
 
N
H
N
CO2MePh
OO
90%, >99% ee
endo:exo >98:2
N
H
N
CO2MePh
OO
91%, >99% ee
endo:exo >98:2
N
H
N
CO2MePh
Ph
OO
86%, 62% ee
endo:exo 90:10
endo-12aa endo-24 endo-25
 
Figure 5. Products obtained from different N-substituted maleimides. 
 
α−Monomethylated and α,β−dimethylated N-
ethylmaleimides 26 and 29, respectively, were prepared22 
and used as dipolarophiles. Non-symmetric maleimide 26 
was an attractive reagent for studying how would be the 
regioselection of this process. When the reaction was 
completed cycloadducts 27 and 28 were obtained in a 44:56 
ratio respectively. This ratio remained unaltered when the 
reaction was run at 0 or at –20 ºC, both in the presence of 
Et3N or DBU. In general, better enantioselection was 
achieved with DBU (84 and 89% ee) (Scheme 4). 
However, no reaction was observed when 3,4-dimethyl-N-
ethylmaleimide 29 was allowed to react with imino ester 
6aa. 
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(DBU)
i
 
 
Scheme 4. Reagents and conditions: i) (S)-Binap 8 (5 mol%), AgClO4 (5 
mol%), Et3N (5 mol%), toluene, rt, 16 h. 
Dipolarophiles different to maleimides were not 
appropriate for the particular requirements of this 
enantioselective 1,3-DC catalyzed by the in situ generated 
complex (S)-16 (Scheme 5 and Table 4). Acrylates 29, 
fumarates 30, maleate 31, and acrylonitrile 32 gave very 
high reaction conversions but the enantioselections never 
exceeded of the 36% ee (Table 4) maintaining the high 
endo:exo diastereoselection. Maleic anhydride, 
nitrostyrene, acrylamide and N-isopropylacrylamide did not 
react at all in spite of using DBU (10 mol%) as base or 
even other chiral ligands 9-11. 
 
N
H
Y
CO2MePh
Ph N CO2Me
6aa
+
Dipolarophile
R
endo-33-36
i
29-32
 
 
Scheme 5. (S)-Binap 8 (5 mol%), AgClO4 (5 mol%), Et3N (5 mol%), 
toluene, rt, 16 h. 
 
 
 
 
 
Table 4. 1,3-DC of iminoester 6aa with several dipolarophiles different to maleimides. 
    Product 
Entry Dipolarophile No. Structure No. Yield (%)a endo:exob eeendo (%)c 
1 CO2Me
 
29a 
N
H
Ph
MeO2C
CO2Me
 
33a 99 >98:2 30 
2 CO2But
 
29d 
N
H
Ph
ButO2C
CO2Me
 
33d 99 >98:2 36 
3 
CO2Me
MeO2C
 
30a 
N
H
Ph
MeO2C
CO2Me
CO2Me
 
34a 99 >98:2 28 
4 
CO2Pri
PriO2C
 
30c 
N
H
Ph
PriO2C
CO2Me
CO2Pri
 
34c 99 >98:2 30 
        
5 
CO2Bui
BuiO2C
 
30e 
N
H
Ph
BuiO2C
CO2Me
CO2Bui
 
34e 99 >98:2 36 
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    Product 
Entry Dipolarophile No. Structure No. Yield (%)a endo:exob eeendo (%)c 
6 CO2MeMeO2C
 
31a 
N
H
Ph
MeO2C
CO2Me
CO2Me
 
35a 99 >98:2 16 
  
   
   
7 CN
 
32 
N
H
Ph
NC
CO2Me
 
36 95 90:10 5 
  
  
    
  
  
    
 
a  Isolated crude yields.  
b  Determined by 1H-MNR.  
c  Determined by chiral HPLC (see experimental part).  
 
2.4. Computational studies. 
 In order to get a better understanding of the behaviour of 
these chiral catalysts, we have carried out DFT23 
calculations on the model reaction depicted in Scheme 1 
and entry 7 of Table 1, using the DFT functional usually 
denoted as B3LYP.24 Silver atoms were treated using the 
Hay and Wadt effective core potential and basis set25 
(denoted as LANL2DZ), whereas the remaining elements 
were described using the standard 6-31G* split-valence 
basis set.26 All the calculations were carried out using the 
GAUSSIAN 03 suite of programs.27 The graphics shown in 
Figures 6 and 7 were built up using the Maestro interface.28 
In the model systems A-C we have included the cationic 
part of the presumed active complex (S)-16 as well as a 
model azomethine ylide and maleimide B. 
 The chief geometric features of complex (S)-A are 
gathered in Figure 6. The azomethine ylide part of (S)-A 
shows different distances for the two C-N bonds. These 
distances are compatible with an iminium-enolate structure 
as shown in Scheme 6, thus anticipating quite 
asynchronous transition structures in the reaction with the 
dipolarophile.  It is also observed that the metallic centre is 
coordinated to the two phosphorus atoms of the catalysts 
and to the oxygen and nitrogen atoms of the azomethine 
ylide. This coordination pattern leads to the blockage of the 
Re face of (S)-A by one of the phenyl groups of the 
phosphine unit (Figure 6).  This steric hindrance is also 
generated by the (S)-Binap moiety, in which the two α-
naphthyl subunits form a dihedral angle of ca. 75 deg. 
Ag
Blockage of the
Re Face
2.567
2.591
2.352
2.375
74.7
(S)-A
Ag
P1
P1
P2
I
II
Dipolarophile
*
*
*
*
1.293
1.374
1.388
1.281
 
Figure 6. I: Fully optimized structure (B3LYP/LANL2DZ&6-31G* level) 
of (S)-A. The hydrogen atoms have been omitted for clarity. The carbon 
atoms of the azomethine ylide moiety have been highlighted with 
asterisks. Bond distances and dihedrals are given in Ǻ and deg., 
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respectively. The molecular surface (Probe radius: 1.4 Ǻ) is also included. 
II: View over the Si face of (S)-A along the axis determined by the Ag and 
P2 atoms. 
 
 
 
P
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N
O H
H
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+
NO O
P
P
Ag
Ph
Ph
Ph
Ph
N
O H
H N
O
O
H
H
P
P
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Ph
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Ph
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N
O H
H N
O
O
H
H
H
H H
(S)-A B
S
S
R S
R
R
endo-(S,S,S,R)-C endo-(S,R,R,S)-D
TS1 TS2 ∆Ea=7.8 kcal/mol∆Ga298=21.9 kcal/mol
∆Ea=5.6 kcal/mol
∆Ga298=19.9 kcal/mol
∆Erxn=-10.1 kcal/mol
∆Grxn298=+4.0 kcal/mol
∆Erxn=-8.8 kcal/mol
∆Grxn298=+5.3 kcal/mol
 
Scheme 6. Model reaction used in the computational studies. The hydrogen atoms highlighted in blue, green and red correspond to a phenyl, a methoxy and 
a methyl group in the reaction depicted in Scheme 1. 
 
 
 In previous work on chiral Ag-based catalysts we have 
observed a clear preference for the endo-cycloadducts 
because of the electrostatic interaction between the nitrogen 
atom of maleimide and the silver atom.12e Therefore, we 
considered the formation of the diastereomeric endo-
cycloadducts C and D via transition structures TS1 and 
TS2, respectively. The main geometric features and the 
relative energies of these transition structures are reported 
in Figure 7. It is found that the Gibbs activation energies 
are larger than the total activation energies because of the 
unfavourable entropic balance on going from the reactants 
to the saddle points, thus resulting in larger reaction times. 
As expected both TS1 and TS2 are quite asynchronous, 
TS1 being ca. 2 kcal/mol more stable than TS2. In this 
latter transition structure there is an appreciable steric clash 
between one of the phenyl groups of the phosphine moiety 
of (S)-16 and the dipolarophile B. This results in a larger 
distortion of the (S)-16 moiety in TS2 with respect to (S)-
A. As a result, exclusive formation of endo-(S,S,S,R)-C is 
predicted, in full agreement with the experimentally 
observed formation of cycloadducts endo described across 
the text. The same trend is found for the cycloadducts 
endo-(S,S,S,R)-C and endo-(S,R,R,S)-D, the latter being ca. 
1.3 kcal/mol less stable than the former. Moreover, the 
slightly positive values of the Gibbs reaction energies 
associated with the formation of these catalyst-bound 
cycloadducts are compatible with the catalyst turnover 
since there is no inhibition of the catalyst by the product of 
the cycloaddition step. These calculations support that 
NMM is the best dipolarophile due to the coordination of 
the nitrogen atom to the metal centre. On the other hand, 
the presence of a bulkier substituent in this nitrogen atom 
blocks the endo-approach reducing the enantioselection, 
such as occurred with NPM. In summary, our calculations 
are in full agreement with the experimental findings and 
provide a rationale for the excellent asymmetric induction 
and catalytic efficiency of species similar to (S)-16. 
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P
P
P
P
Ag
Ag
75.4
73.5
2.019
2.696
3.910
3.541 2.864
2.029
2.550
2.718
2.316
2.536
2.616
2.636
2.358
2.511
TS2
(+2.2 kcal/mol)
[+2.0 kcal/mol]
TS1
(0.0)
[0.0]
S
R
S
S
R
R
Figure 7. Fully optimized structure (B3LYP/LANL2DZ&6-31G* level) 
of TS1 and TS2, leading to endo-(S,S,R)-C and endo-(S,R,R,S)-D, 
respectively. The hydrogen atoms have been omitted for clarity. Bond 
distances and dihedrals are given in Ǻ and deg., respectively. Numbers in 
parentheses and in square brackets are the relative total and Gibbs free 
energies respectively, computed at the B3LYP/LANL2DZ&6-
31G*+∆ZPVE level. 
 
3. Conclusions 
 Evaluating all the data described in the main text, the 
employment of the complex generated by the 1:1 mixture 
of chiral Binap and AgClO4 is very stable and can be 
manipulate without any special care. It was efficient in the 
catalyzed 1,3-DC using maleimides and aryliminoesters, 
however other dipolarophiles did not work satisfactorily. 
The whole catalytic mixture can be recovered from the 
reaction mixture and reused without any loss of efficiency. 
The TS responsible of the enantiodiscrimination is, as 
expected, quite asynchronous, an appreciable steric clash 
between one of the phenyl groups of the phosphine moiety 
of (S)-16 and the dipolarophile being the crucial 
interaction.  
 
4. Experimental section 
4.1.General 
 All reactions were carried out in the absence of light. 
Anhydrous solvents were freshly distilled under an argon 
atmosphere. Aldehydes were also distilled prior to use for 
the elaboration of the iminoesters. Melting points were 
determined with a Reichert Thermovar hot plate apparatus 
and are uncorrected. Only the structurally most important 
peaks of the IR spectra (recorded on a Nicolet 510 P-FT) 
are listed. 1H NMR (300 MHz) and 13C NMR (75 MHz) 
spectra were obtained on a Bruker AC-300 using CDCl3 as 
solvent and TMS as internal standard, unless otherwise 
stated. Optical rotations were measured on a Perkin Elmer 
341 polarimeter. HPLC analyses were performed on a 
JASCO 2000-series equipped with a chiral column 
(detailed for each compound in the main text), using 
mixtures of n-hexane/isopropyl alcohol as mobile phase, at 
25 ºC. Low-resolution electron impact (EI) mass spectra 
were obtained at 70eV on a Shimadzu QP-5000 and high-
resolution mass spectra were obtained on a Finnigan VG 
Platform. HRMS (EI) were recorded on a Finnigan MAT 
95S. Microanalyses were performed on a Perkin Elmer 
2400 and a Carlo Erba EA1108. Analytical TLC was 
performed on Schleicher & Schuell F1400/LS silica gel 
plates and the spots were visualized under UV light (λ=254 
nm). For flash chromatography we employed Merck silica 
gel 60 (0.040-0.063 mm). 
4.2. 1,3-Dipolara cycloaddition of iminoesters 6 and 
dipolarophiles. General procedure. 
A solution of the imino ester  (1 mmol) and dipolarophile 
(1 mmol) in toluene (5 mL) was added to a suspension 
containing  (R)- or (S)-Binap (0.05 mmol, 31 mg) and 
AgClO4 (0.05 mmol, 10 mg) in toluene (5 mL). To the 
resulting suspension triethylamine (0.05 mmol, 7 µL) was 
added and the mixture stirred at room temperature and in 
the absence of the light for 16-48 h (see main text). The 
precipitate was filtered  and the complex was recovered. 
The organic filtrate was directly evaporated and the residue 
was purified by recrystallization or by flash 
chromatography yielding pure endo-cycloadducts. 
The solid was washed with warm toluene twice and then 
dissolved in DCM in order to transfer the catalytic complex  
into the flask. After evaporation of DCM the resulting solid 
was ready to catalyze a new batch. 
 
4.2.1. Methyl (1S,3R,3aS,6aR)-5-methyl-3-phenyl-4,6-
dioxooctahydropyrrolo[3,4-c]pyrrole-1-carboxylate 
12aa.12a,19 
 
4.2.2. Ethyl (1S,3R,3aS,6aR)-5-methyl-3-phenyl-4,6-
dioxooctahydropyrrolo[3,4-c]pyrrole-1-carboxylate 12ab. 
Colorless prisms, mp, 195-197 ºC (CH2Cl2/hex); [α]D20 
= +74º (c 1, CHCl3, 90% ee from HPLC); Rf: 0.36 (n-
hexane/ethyl acetate: 1/5); IR (KBr) ν: 1752, 1702, 3325 
cm-1; 1H NMR δH: 1.38 (t, J = 7.1 Hz, 3H, CO2CH2CH3), 
2.41 (br s, 1H, NH), 2.85 (s, 3H, NCH3), 3.41 (dd, J = 8.2, 
8.0 Hz, 1H, CHCHAr), 3.55 (dd, J = 7.3, 7.1 Hz, 1H, 
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CHCHCO2Et), 4.01 (d, J = 5.7 Hz, 1H, CHCO2CH3), 4.32 
(m, 2H, CO2CH2CH3), 4.47 (d, J = 8.1 Hz, 1H, CHPh), 
7.28-7.36 (m, 5H, ArH); 13C NMR δC: 14.1 (CO2CH2CH3), 
24.9 (NCH3), 48.1, 49.5 (2CHCON), 61.3 (CO2CH2CH3), 
61.7 (CHCO2Et), 63.9 (Ph-CH), 126.9, 128.2, 128.3 
(ArCH), 136.7 (ArC), 169.6, 174.7, 175.8 (CO2Me and 
CON); MS (EI) m/z (%): 302 (M+, 3.90%), 230 (16), 229 
(100), 191 (37), 144 (37), 117 (43); HRMS calcd. for 
C16H18N2O4: 302.1267, found: 302.1292; Microanalysis 
calcd. for C16H18N2O4: C, 63.5; H, 6.0; N, 9.2, found: C, 
63.5; H, 5.7; N, 9.1; HPLC (Chiralcel ODH, 1 mL/min, n-
hexane/i-PrOH: 80/20, λ 215 nm), tRmaj = 24.1 min, tRmin = 
25.8 min. 
 
4.2.3. Isopropyl (1S,3R,3aS,6aR)-5-methyl-3-phenyl-4,6-
dioxooctahydropyrrolo[3,4-c]pyrrole-1-carboxylate 12ac. 
Colorless prisms, mp, 202 ºC (CH2Cl2/hex); [α]D20 = +63º 
(c 0.7, CHCl3, 99% ee from HPLC); Rf: 0.50 
(n-hexane/ethyl acetate: 1/5); IR (KBr) ν: 1735, 1703, 3328 
cm-1; 1H NMR δH: 1.33 [d, J = 6.2 Hz, 3H, CO2CH(CH3)2], 
1.41 [d, J = 6.3 Hz, 3H, CO2CH(CH3)2], 2.42 (br s, 1H, 
NH), 2.87 (s, 3H, NCH3), 3.43 (dd, J = 8.3, 8.0 Hz, 1H, 
CHCHPh), 3.56 (dd, J = 7.2, 7.1 Hz, 1H, CHCHCO2Pri), 
4.00 (dd, J = 6.7, 5.7 Hz, 1H, CHCO2Pri), 4.49 (dd, J = 8.4, 
5.8 Hz, 1H, CHPh), 5.22 [m, 1H, CO2CH(CH3)2], 7.29-7.40 
(m, 5H, ArH); 13C NMR δC: 21.6, 21.9 [CO2CH(CH3)2], 
24.9 (NCH3), 48.2, 49.7 (2CHCON), 62.0 [CO2CH(CH3)2], 
64.0 (CHCO2 Pri), 69.3 (Ph-CH), 126.6, 128.3, 128.4 
(ArCH), 136.6 (ArC), 169.1, 174.8, 175.8 (CO2Me and 
CON); MS (EI) m/z (%):316 (M+, 2.23%), 230 (15), 229 
(100), 205 (14), 144 (29), 117 (19); HRMS calcd. for 
C17H20N2O4: 316.1423, found: 316.1426; Microanalysis 
calcd. for C17H20N2O4: C, 64.5; H, 6.3; N, 8.8, found: C, 
64.5; H, 6.3; N, 8.5; HPLC (Chiralcel OD-H, 1 mL/min, n-
hexane/i-PrOH: 80/20, λ 215 nm), tRmaj = 21.5 min, tRmin = 
33.4 min. 
 
4.2.4. tert-Butyl (1S,3R,3aS,6aR)-5-methyl-3-phenyl-4,6-
dioxooctahydropyrrolo[3,4-c]pyrrole-1-carboxylate 12ad. 
Colorless prisms, mp, 210 ºC (subl.) (CH2Cl2/hex); [α]D20 = 
+33.9º (c 0.8, CHCl3, 92% ee from HPLC); Rf: 0.39 (n-
hexane/ethyl acetate: 1/5); IR (KBr) ν: 1734, 1705, 3328 
cm-1; 1H NMR δH: 1.58 [s, 9H, CO2C(CH3)3], 2.40 (br s, 
1H, NH), 2.86 (s, 3H, NCH3), 3.42 (dd, J = 8.2, 8.1 Hz, 1H, 
CHCHPh), 3.54 (dd, J = 7.2, 7.1 Hz, 1H, CHCHCO2But), 
3.94 (m, 1H, CHCO2But), 4.49 (dd, J = 8.5, 6.1 Hz, 1H, 
CHPh), 7.26-7.36 (m, 5H, ArH); 13C NMR δC: 24.9 
(NCH3), 28.1 [CO2C(CH3)3].48.2, 49.8 (2CHCON), 62.4 
(CHCO2But), 63.8 (Ph-CH), 82.5 [CO2C(CH3)3], 126.6, 
128.2, 128.4 (ArCH), 136.7 (ArC), 174.8, 175.8 (CON); 
MS (EI) m/z (%):330 (M+, 0.01%), 230 (18), 229 (100), 
144 (25)117 (18); HRMS calcd. forC18H22N2O4: 330.1580, 
found: 229.0986; Microanalysis calcd. for C18H22N2O4: C, 
65.4; H, 6.7; N, 8.5, found: C, 65.4; H, 6.6; N, 8.3; HPLC 
(Chiralcel ODH, 1 mL/min, n-hexane/i-PrOH: 70/30, λ 215 
nm), tRmaj = 12.1 min, tRmin = 17.3 min. 
 
4.2.5. Methyl (1S,3R,3aS,6aR)-5-methyl-3-(2-naphthyl)-
4,6-dioxooctahydropyrrolo[3,4-c]pyrrole-1-carboxylate 
12ba11h 
 
4.2.6. tert-Butyl (1S,3R,3aS,6aR)-5-methyl-3-(2-naphthyl)-
4,6-dioxooctahydropyrrolo[3,4-c]pyrrole-1-carboxylate 
12bd. Colorless prisms, mp, 150-152 ºC (CH2Cl2/hex); 
[α]D20 = +39.8º (c 1, CHCl3, 92% ee from HPLC, 75:25 
endo/exo); Rf: 0.46 (n-hexane/ethyl acetate: 1/5); IR (KBr) 
ν: 1715, 1689, 1678, 3341 cm-1; 1H NMR δH: 1.32 [s, 9H, 
CO2C(CH3)3], 2.29 (br s, 1H, NH), 3.05 (s, 3H, NCH3), 
3.56 (m, 1H, CHCHAr), 3.86 (m, 1H, CHCHCO2CH3), 
4.00 (d, J = 4.2 Hz, 1H, CHCO2CH3), 4.65 (d, J = 4.9 Hz, 
1H, CHAr), 7.40-7.49 (m, 3H, ArH), 7.80-7.86 (m, 4H, 
ArH); 13C NMR δC: 25.2 (NCH3), 27.7 [CO2C(CH3)3].48.2, 
49.1, 52.0 (2CHCON and CO2CH3), 63.3 (CHCO2But), 
65.3 (2-Napht-CH), 82.6 [CO2C(CH3)3], 124.8, 125.2, 
126.2, 126.4, 127.6, 128.0, 128.7 (ArCH), 133.0, 133.3 
137.9 (ArC), 170.4, 176.9, 177.1 (CO2 But and CON); MS 
(EI) m/z (%): 380 (M+, 1.78%), 280 (18), 279 (100), 194 
(22), 167 (13); HRMS calcd. for C22H24N2O4: 380.1736, 
found: 380.1725; Microanalysis calcd. for C22H24N2O4: C, 
69.5; H, 6.4; N, 7.4, found: C, 69.5; H, 6.3; N, 7.1; HPLC 
(Chiralcel OD-H, 1 mL/min, n-hexane/i-PrOH: 70/30, λ 
225 nm), tRmaj = 13.5 min, tRmin = 22.0 min. 
 
4.2.7. Methyl (1S,3R,3aS,6aR)-5-methyl-4,6-dioxo-3-o-
tolyloctahydropyrrolo[3,4-c]pyrrole-1-carboxylate 12ca. 
Colorless prisms, mp, 151 ºC (CH2Cl2/hex); [α]D20 =  50,8º 
(c 0.6, CHCl3, 75% ee from HPLC); Rf: 0.25 (n-
hexane/ethyl acetate: 1/5); IR (KBr) ν: 1768, 1734, 1698, 
2954 cm-1; 1H NMR δH: 2.35 (s, 3H, ArCH3),  2.75 (s, 3H, 
NCH3), 3.46 (m, 1H, CHCHAr), 3.67 (m, 1H, 
CHCHCO2CH3), 3.82 (s, 3H, CO2CH3), 3.99 (d, J = 6.2 Hz, 
1H, CHCO2CH3), 4.54 (d, J = 8.1 Hz, 1H, CHAr), 7.08-
7.15 (m, 3H, ArH), 7.36-7.39 (m, 1H, ArH); 13C NMR δC: 
19.4 (ArCH3), 24.9 (NCH3), 46.9, 48.0, 52.3 (2CHCON 
and CO2CH3), 61.2 (CHCO2Me), 67.9 (2-MePh-CH), 
125.1, 126.1, 127.8, 130.1 (ArCH), 135.2, 135.5 (ArC), 
170.2, 174.4, 176.1 (CO2Me and CON); MS (EI) m/z (%): 
302 (M+, 15.36%), 243 (67), 244 (10), 193 (10), 192 (85), 
191 (78), 160 (28), 159 (11), 158 (38), 132 (38), 131 (100), 
130 (36), 118 (15), 115 (14), 105 (20), 104 (11), 103 (13), 
91 (15), 77 (11); HRMS calcd. for C16H18N2O4: 302.1267, 
found: 302.1247; Microanalysis calcd. for C16H18N2O4: C, 
63.6; H, 6.0; N, 9.3, found: C, 63.6; H, 6.3; N, 9.0; HPLC 
(Chiralcel OD-H, 1 mL/min, n-hexane/i-PrOH: 70/30, λ 
225 nm), tRmin = 24.7 min, tRmaj = 28.1 min. 
 
4.2.8. Methyl (1S,3R,3aS,6aR)-3-(2-chlorophenyl)-5-
methyl-4,6-dioxooctahydropyrrolo[3,4-c]pyrrole-1-
carboxylate 12da.11h 
 
4.2.9. Methyl (1S,3R,3aS,6aR)-5-methyl-3-(4-
methylphenyl)-4,6-dioxooctahydropyrrolo[3,4-c]pyrrole-1-
carboxylate 12ea.11h 
4.2.10. Methyl (1S,3R,3aS,6aR)-3-(4-methoxyphenyl)-5-
methyl-4,6-dioxooctahydropyrrolo[3,4-c]pyrrole-1-
carboxylate 12fa.11h 
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4.2.11. tert-Butyl (1S,3R,3aS,6aR)-3-(4-methoxyphenyl)-5-
methyl-4,6-dioxooctahydropyrrolo[3,4-c]pyrrole-1-
carboxylate (12fd). Colorless prisms, mp, 179 ºC 
(CH2Cl2/hex); [α]D20 = 93º (c 0.5, CHCl3, 84% ee from 
HPLC); Rf: 0.29 (n-hexane/ethyl acetate: 1/5); IR (KBr) ν: 
1702, 1733, 2977 cm-1; 1H NMR δH: 1.58 [s, 9H, 
CO2C(CH3)3], 1.86 (br s, 1H, NH), 2.88 (s, 3H, NCH3), 
3.38 (dd, J = 8.2, 8.0 Hz, 1H, CHCHAr), 3.53 (dd, J = 7.1, 
7.0 Hz, 1H, CHCHCO2But), 3.80 (s, 3H, OCH3), 3.92 (d, J 
= 6.7 Hz, 1H, CHCO2But), 4.43 (d, J = 8.6 Hz, 1H, CHAr), 
6.87 (d, J = 8.7 Hz, 2H, ArH), 7.24 (d, J = 8.7 Hz, 2H, 
ArH); 13C NMR δC: 24.9 (NCH3), 28.1 [CO2C(CH3)3], 
48.2, 49.7 (2CHCON), 55.1 (OCH3), 62.3 (CHCO2But), 
63.4 (4-MeOPh-CH), 82.5 [CO2C(CH3)3], 113.7, 128.1 
(ArCH), 159.3, 168.6 (ArC), 175.1, 175.9 (CON); MS (EI) 
m/z (%):360 (M+, 4.15%), 260 (15), 259 (100), 249 (12), 
193 (45), 174 (24), 147 (29); HRMS calcd. for C19H24N2O5: 
360.1685, found: 360.1674; Microanalysis calcd. for 
C19H24N2O5: C, 63.3; H, 6.7; N, 7.7, found: C, 63.5; H, 6.6; 
N, 7.4; HPLC (Chiralpak AS, 1 mL/min, n-hexane/i-PrOH: 
90/10, λ 205 nm), tRmin = 25.2 min, tRmaj = 43.7 min. 
 
4.2.12. Methyl (1S,3R,3aS,6aR)-3-(4-chlorophenyl)-5-
methyl-4,6-dioxooctahydropyrrolo[3,4-c]pyrrole-1-
carboxylate 12ga.11h 
 
4.2.13. tert-Butyl (1S,3R,3aS,6aR)-3-(4-chlorophenyl)-5-
methyl-4,6-dioxooctahydropyrrolo[3,4-c]pyrrole-1-
carboxylate 12gd. Colorless prisms, mp, 129-131 ºC 
(CH2Cl2/hex); [α]D20 = +16º (c 0.5, CHCl3, 82% ee from 
HPLC); Rf: 0.36 (n-hexane/ethyl acetate: 1/5); IR (KBr) ν: 
1729, 1708, 3328 cm-1; 1H NMR δH: 1.57 [s, 9H, 
CO2C(CH3)3], 2.39 (br s, 1H, NH), 2.84 (s, 3H, NCH3), 
3.41 (dd, J = 8.2, 8.1 Hz, 1H, CHCHAr), 3.54 (dd, J = 7.6, 
6.9 Hz, 1H, CHCHCO2But), 3.95 (dd, J = 6.4, 5.7 Hz, 1H, 
CHCO2But), 4.45 (dd, J = 8.6, 5.8 Hz, 1H, CHAr), 7.24-
7.31 (m, 5H, ArH); 13C NMR δC: 24.9 (NCH3), 28.0 
[CO2C(CH3)3], 47.8, 49.4 (2CHCON), 62.2 (CHCO2But), 
63.0 (p-Cl-CH), 82.6 [CO2C(CH3)3], 128.3, 128.6 (ArCH), 
133.9, 135.3 (ArC), 174.6, 175.6 (CON); MS (EI) m/z 
(%):364 (M+, 0.21%), 265 (32), 264 (15), 263 (100), 178 
(21), 151 (10), 143 (11), 57 (12); HRMS calcd. for 
C18H21ClN2O4: 364.1190, found: 364.1207 ; Microanalysis 
calcd. for C18H21ClN2O4: C, 59.3; H, 5.8; N, 7.7, found: C, 
59.1; H, 5.8; N, 7.4; HPLC (Chiralcel ODH, 1 mL/min, n-
hexane/i-PrOH: 80/20, λ 215 nm), tRmaj = 14.5 min, tRmin = 
26.5 min. 
 
4.2.14. Methyl (1S,3R,3aS,6aR)-5-methyl-4,6-dioxo-3-(2-
thienyl)octahydropyrrolo[3,4-c]pyrrole-1-carboxylate 
12ha.11h 
 
4.2.15. Methyl (1S,3R,3aS,6aR)-1,5-dimethyl-4,6-dioxo-3-
phenyloctahydropyrrolo[3,4-c]pyrrole-1-carboxylate 21.11h 
 
4.2.16. Methyl (1S,3R,3aS,6aR)-1-benzyl-5-methyl-4,6-
dioxo-3-phenyloctahydropyrrolo[3,4-c]pyrrole-1-
carboxylate 22.11h 
 
4.2.17. Methyl (1S,3R,3aS,6aR)-1-isobutyl-5-methyl-4,6-
dioxo-3-(2-thienyl)octahydropyrrolo[3,4-c]pyrrole-1-
carboxylate 23.11h 
 
4.2.18. Methyl (1S,3R,3aS,6aR)-5-ethyl-3-phenyl-4,6-
dioxooctahydropyrrolo[3,4-c]pyrrole-1-carboxylate 
24.12a,19 
 
4.2.19. Methyl (1S,3R,3aS,6aR)-3,5-diphenyl-4,6-
dioxooctahydropyrrolo[3,4-c]pyrrole-1-carboxylate 
25.12a,19 
 
4.2.20. Methyl (1S,3R,3aS,6aR)-5-ethyl-3a-methyl-3-
phenyl-4,6-dioxooctahydropyrrolo[3,4-c]pyrrole-1-
carboxylate 27. (Isolated together isomer 28): 1H NMR 
δH:1.09 (t, J = 7.2 Hz, 3H, NCH2CH3), 1.49 (s, 3H, CCH3), 
2.39 (br s, 1H, NH), 3.12 (d, J = 6.4 Hz, 1H, 
CHCHCO2CH3), 3.43 (m, 2H, NCH2CH3), 3.87 (s, 3H, 
CO2CH3), 4.00 (br s, 1H, CHPh), 4.07 (d, J = 4.4, Hz, 1H, 
CHCO2CH3), 7.32-7.34 (m, 4H, ArH); 13C NMR δC: 13.1 
(CH2CH3), 20.0 (CCH3), 33.9 (CH2CH), 52.2 (CO2CH3), 
54.5 (CHCON), 54.6 (CCH3), 60.4 (CHCO2Me), 71.9 (Ph-
CH), 126.9, 128.2, 128.5 (ArCH), 136.6, 136.9 (ArC), 
170.2, 173.9, 175.1 (CO2Me and CON). 
 
4.2.21. Methyl (1S,3R,3aS,6aR)-5-ethyl-6a-methyl-3-
phenyl-4,6-dioxooctahydropyrrolo[3,4-c]pyrrole-1-
carboxylate 28. (Isolated together isomer 27). 1H NMR 
δH:1.09 (t, J = 7.2 Hz, 3H, NCH2CH3), 1.60 (s, 3H, CCH3), 
2.39 (br s, 1H, NH), 2.98 (d, J = 8.4 Hz, 1H, CHCHPh), 
3.43 (m, 2H, NCH2CH3), 3.71 (d, J = 3.4 Hz, 1H, 
CHCO2CH3), 3.87 (s, 3H, CO2CH3), 4.53 (dd, J = 8.2, 4.1, 
Hz, 1H, CHAr), 7.32-7.34 (m, 4H, ArH); 13C NMR δC: 13.1 
(CH2CH3), 20.0 (CCH3), 33.9 (CH2CH), 52.2 (CO2CH3), 
54.6 (CCH3), 56.9 (CHCON), 63.0 (Ph-CH), 68.2 
(CHCO2Me), 126.9, 128.2, 128.5 (ArCH), 136.6, 136.9 
(ArC), 170.2, 177.3, 178.7(CO2Me and CON) 
 
4.2.22. Dimethyl (2S,4S,5R)-5-phenylpyrrolidine-2,4-
dicarboxylate 33a.11b 
 
4.2.23. 4-tert-Butyl 2-methyl (2S,4S,5R)-5-
phenylpyrrolidine-2,4-dicarboxylate 33b.11b 
 
4.2.24. Trimethyl  (2S,3S,4S,5R)-5-phenylpyrrolidine-2,3,4-
tricarboxylate 34a.12a,19 
 
4.2.25. 3,4-Diisopropyl (2S,3S,4S,5R)-2-methyl-5-
phenylpyrrolidine-2,3,4-tricarboxylate 34c. Sticky oil; 
[α]D20 =  32,1º (c 0.5, CHCl3.82% ee from HPLC); Rf: 0.37 
(n-hexane/ethyl acetate: 3/2); IR (liq.) ν: 1741, 1731, 2982 
cm-1; 1H NMR δH: 0.65 [d, J = 6.2 Hz, 3H, CH(CH3)2], 
0.94 [d, J = 6.2 Hz, 3H, CH(CH3)2], 1.27 [d, J = 6.2 Hz, 
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3H, CH(CH3)2], 1, 28 [d, J = 6.2 Hz, 3H, CH(CH3)2], 2.86 
(br s, 1H, NH), 3.55 (m, 2H, 2×CHCO2Pri), 3.83 (s, 3H, 
CO2CH3), 4.14 (d, J = 7.3 Hz, 1H, CHCO2Me), 4.56 [sept, 
J = 6.2 Hz, 1H, CH(CH3)2], 4.65 (d, J = 7.3 Hz, 1H, 
CH-Ph), 5.08 [sept, J = 6.2 Hz, 1H, CH(CH3)2], 7.22-7.34 
(m, 5H, ArH); 13C NMR δC: 20.8, 21.4, 21.6 [CH(CH3)2], 
51.4, 52.4 (CHCO2Pri), 53.8 (CO2CH3), 63.4 [CHCO2Me], 
65.2 (Ph-CH), 68.2, 68.8 [CH(CH3)2], 127.0, 127.7, 128.2 
(ArCH), 138.4 (ArC), 170.5, 171.5, 171.6 (CO2Me, 
CO2Pri); MS (EI) m/z (%): 377 (M+, 13.84%), 318 (33), 
317 (23), 316 (23), 290 (20), 276 (17), 274 (12), 258 (38), 
248 (15), 230 (43), 228 (17), 216 (10), 205 (25), 202 (50), 
188 (47), 187 (23), 177 (67), 170 (34), 149 (12), 146 (29), 
145 (46), 144 (100), 143 (29), 119 (22), 118 (19), 117 (96), 
116 (14), 115 (28), 106 (11), 104 (10), 91 (12), 90 (10); 
HRMS calcd. for C20H27NO6: 377.1838, found: 377.1863; 
HPLC (Chiralcel OD-H, 1 mL/min, n-hexane/i-PrOH: 
80:20, λ 220 nm), tRmaj = 6.6 min, tRmin = 13.5 min. 
 
4.2.26. 3,4-Diisobutyl 2-methyl (2S,3S,4S,5R)-5-
phenylpyrrolidine-2,3,4-tricarboxylate 35e. Sticky oil; 
[α]D20 =  47,1º (c 0.5, CHCl3.82% ee from HPLC); Rf: (n-
hexane/ethyl acetate: 1/5); IR (liq.) ν: 1737, 1730, 2958 
cm-1; 1H NMR δH: 0.66 [d, J = 6.7 Hz, 3H, CH(CH3)2], 
0.68 [d, J = 6.6 Hz, 3H, CH(CH3)2], 0.95 [d, J = 6.7 Hz, 
6H, CH(CH3)2], 1.51 [d, J = 6.7 Hz, 1H, CH(CH3)2], 1.63 
(br s, 1H, NH), 1.97 [d, J = 6.7 Hz, 1H, CH(CH3)2], 3.25 
[dd, J = 10.5, 6.6 Hz, 1H, CH2CH(CH3)2], 3.50 [dd, J = 
10.6, 6.6 Hz, 1H, CH2CH(CH3)2], 3.63 (m, 2H, 
2×CHCO2Bui), 3.83 (s, 3H, CO2CH3), 3.96 [m, 2H, 
CH2CH(CH3)2], 4.19 (d, J = 7.3 Hz, 1H, CHCO2Me), 4.66 
(d, J = 7.5 Hz, 1H, CH-Ph), 7.25-7.32 (m, 5H, ArH); 13C 
NMR δC: 18.8, 18.9, 19.0 [CH(CH3)2], 27.2, 27.7 
[CH(CH3)2], 51.3 (CHCO2Bui), 52.5 (CO2CH3), 54.0 
(CHCO2Bui), 63.4 [CHCO2Me], 65.5 (Ph-CH), 71.1, 71.5 
(CH2), 126.9, 127.8, 128.3 (ArCH), 138.1 (ArC), 171.4, 
172.1, 172.2 (CO2Me, CO2Bui); MS (EI) m/z (%): 405 (M+, 
10.61%), 346 (11), 345 (22), 332 (20), 304 (20), 272 (36), 
245 (11), 244 (54), 219 (11), 202 (38), 188 (38), 178 (11), 
177 (90), 170 (26), 164 (46), 155 (12).149 (14), 146 (54), 
145 (46), 144 (82), 143 (24), 119 (12), 118 (19), 117 (100), 
116 (13), 115 (21), 106 (11), 105 (11), 90 (11), 57 (46), 56 
(21), 55 (12); HRMS calcd. for C22H31NO6: 405.2151, 
found: 405.2171; HPLC (Chiralcel OD-H, 1 mL/min, n-
hexane/i-PrOH: 80:20, λ 220 nm), tRmaj = 8.5 min, tRmin = 
16.7 min. 
 
4.2.27. Trimethyl (2S,3R,4S,5R)-5-phenylpyrrolidine-2,3,4-
tricarboxylate 35a.12a,19 
 
4.2.28. Methyl (2S,4S,5R)-4-cyano-5-phenylpyrrolidine-2-
carboxylate 36.29 
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